Medical Director Oncology Research and Innovation

Cooper Norcross Health, formerly Cooper University Health Care, is a leading academic health system affiliated with Cooper Norcross Medical School of Rowan University. Headquartered in Camden, New Jersey, Cooper Norcross Health has revenues of more than $3 billion and an A+ credit rating from both S&P and Fitch Ratings.

Cooper Norcross Health has nearly 14,000 team members, including more than 2,200 nurses, more than 1,200 employed physicians representing 95 specialties and subspecialties, and more than 700 advanced practice providers.

The health system operates MD Anderson Cancer Center at Cooper as well as four hospitals – its 663-bed flagship Cooper Norcross University Hospital in Camden, its 229-bed Cooper Norcross University Hospital Cape Regional in Cape May Court House,  Children’s Hospital at Cooper Norcross Health in Camden, and The Recovery Village Cherry Hill at Cooper, a substance abuse rehabilitation and inpatient treatment facility, in partnership with American Recovery Services.

Cooper Norcross University Hospital in Camden is the only Level 1 Trauma Center in South Jersey and the busiest in the region. The hospital has been recognized as a top-performing regional hospital by U.S. News & World Report’s Best Hospitals annual survey for eight years.

More than 2.54 million patients visit Cooper Norcross Health facilities annually. Its ambulatory network encompasses three outpatient surgery centers, seven urgent care centers, a wound care center, and more than 130 physician, physical therapy, and radiology offices extending from the Delaware River to the New Jersey shore.

Cooper Norcross Health, a not-for-profit health system, was named one of America’s Best Large Employers for 2026 by Forbes, ranking among the top 200 in the nation. Visit CooperHealth.org to learn more.

This is a unique leadership opportunity to shape the future of cancer research at a top-tier cancer center affiliated with MD Anderson Cancer Center in Houston. You will play a key role in driving clinical innovation, expanding access to groundbreaking treatments, and fostering interdisciplinary collaboration in the fight against cancer.

MD Anderson Cancer Center at Cooper is seeking an experienced and visionary Medical Oncologist & Director of Clinical Research to lead and expand our clinical trial portfolio, establish a Phase 1 clinical trials program, and strengthen collaborations with MD Anderson Cancer Center in Houston, pharmaceutical partners, and internal multidisciplinary teams. This role is pivotal in advancing cutting-edge cancer research and fostering collaboration with surgical oncology and the Camden Cancer Research Collaborative to enhance translational research efforts. 

Key Responsibilities

Clinical Research Leadership & Expansion

• Develop and implement a strategic plan to expand the clinical trial portfolio, ensuring access to innovative treatment options for patients.
  
• Lead the establishment of a Phase 1 clinical trials program, ensuring infrastructure and resources support early-phase research.
  
• Enhance clinical trial enrollment and streamline trial operations to maximize efficiency and patient access.

Collaboration & Partnership Development

• Strengthen research partnerships with MD Anderson Cancer Center in Houston, securing access to novel clinical trials and research initiatives.
• Build and maintain strong relationships with pharmaceutical companies and industry sponsors to support trial development and funding opportunities.
• Foster collaboration with surgical oncology, radiation oncology, and the Camden Cancer Research Collaborative to drive translational research efforts.

Oncology Research Operations & Integration

• Work closely with research administration, regulatory teams, and clinical staff to ensure compliance with GCP (Good Clinical Practice) guidelines and institutional policies.
• Mentor and guide faculty, fellows, and research staff in clinical trial design, execution, and publication.
• Advocate for infrastructure improvements that support trial expansion, including patient recruitment strategies, data management, and research support services

• MD or DO with board certification in Medical Oncology.
  Strong background in clinical trial leadership, with experience in Phase 1 clinical research preferred.
• Established track record of collaboration with pharmaceutical sponsors and industry
  partners.
• Demonstrated ability to work effectively in a multidisciplinary research environment,
  including engagement with surgical and translational research teams.
• Experience in academic research, including publications and grant funding, is highly
  desirable.